Pharmaceutical Executive-04-01-2008

Pharmaceutical Executive
Thought Leader

April 01, 2008

Veteran salesperson Reggie Smith of Genentech makes the case for sales force diversity

Pharmaceutical Executive

New study ranks the top RX product sites and looks at the consumers who view them

Pharmaceutical Executive
Commentary

April 01, 2008

Pharma is embracing the cross-functional team. But that doesn't mean that you must blend in with the sheep. Putting your best foot forward strengthens the team...and you.

Pharmaceutical Executive
Features

April 01, 2008

Here's the saga of how market research, health outcomes, and dozens of other tools that connect the industry to patients came to be.

Pharmaceutical Executive
Leadership

April 01, 2008

Everyone likes to work for a successful company. But how do you drive your initiatives to the top? Never underestimate courage and persistence.

Pharmaceutical Executive
Washington Report

April 01, 2008

International outsourcing carries risks for marketers and regulatory challenges for FDA

Pharmaceutical Executive
Legal

April 01, 2008

A little-known provision in a new law rewards employees for blowing the whistle on tax fraud. Pharma should examine its tricky tax situation-and work out the issues on a global level.

Pharmaceutical Executive
From the Editor

April 01, 2008

The real question in the Baxter heparin scandal is not who's guilty but whether pharma can get reliable results from a country in chaos

Pharmaceutical Executive
Column

April 01, 2008

Talk to MDs in their language and build a better brand

Features
Pharmaceutical Executive

April 01, 2008

...and other ways you never thought to sell your drugs

Pharmaceutical Executive
Column

April 01, 2008

What Big Pharma needs to learn-and value-about this rapidly growing US demographic

Features
Pharmaceutical Executive

April 01, 2008

The contamination of heparin in China cast the drugmaker, its US supplier, and FDA as indifferent and incompetent. Then the story took a very strange turn...

Pharmaceutical Executive
Global Report

April 01, 2008

Can ceasing trade sales and finding funding help UK biotechs became an industry in their own right?

Pharmaceutical Executive
Column

April 01, 2008

When it comes to developing novel therapies from the animal kingdom, it's mostly a game of pick your poison

Pharmaceutical Executive
From the Editor

April 01, 2008

The real question in the Baxter heparin scandal is not who's guilty but whether pharma can get reliable results from a country in chaos